LABD vs. PBE ETF Comparison

Comparison of Direxion Daily S&P Biotech Bear 3X Shares (LABD) to PowerShares Dynamic Biotech & Genome (PBE)
LABD

Direxion Daily S&P Biotech Bear 3X Shares

LABD Description

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.

Grade (RS Rating)

Last Trade

$5.76

Average Daily Volume

15,699,334

Number of Holdings *

79

* may have additional holdings in another (foreign) market
PBE

PowerShares Dynamic Biotech & Genome

PBE Description The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$69.14

Average Daily Volume

6,628

Number of Holdings *

30

* may have additional holdings in another (foreign) market
Performance
Period LABD PBE
30 Days -3.36% -0.97%
60 Days 6.17% -3.80%
90 Days -9.66% 0.98%
12 Months -75.44% 26.96%
21 Overlapping Holdings
Symbol Grade Weight in LABD Weight in PBE Overlap
ACAD F 1.68% 2.62% 1.68%
ALNY C 1.73% 5.57% 1.73%
AMGN C 1.75% 5.1% 1.75%
BIIB F 1.65% 4.77% 1.65%
BMRN F 1.89% 4.1% 1.89%
BPMC C 1.61% 2.62% 1.61%
CDNA D 0.93% 2.1% 0.93%
CPRX A 0.53% 3.01% 0.53%
EXEL A 1.91% 3.18% 1.91%
HALO B 0.71% 2.32% 0.71%
INCY A 1.51% 2.87% 1.51%
MYGN F 1.08% 2.34% 1.08%
NBIX C 1.62% 4.0% 1.62%
NTRA B 1.08% 2.85% 1.08%
OPK C 0.35% 2.56% 0.35%
REGN F 1.77% 4.15% 1.77%
TGTX A 0.55% 2.89% 0.55%
UTHR A 1.78% 5.35% 1.78%
VCEL D 0.34% 2.28% 0.34%
VCYT A 0.72% 2.93% 0.72%
XNCR A 0.49% 3.55% 0.49%
LABD Overweight 58 Positions Relative to PBE
Symbol Grade Weight
BLUE F 1.87%
VRTX D 1.84%
SAGE F 1.8%
EXAS A 1.73%
ABBV A 1.72%
SRPT D 1.66%
IONS F 1.64%
GILD A 1.64%
RARE D 1.49%
MRNA F 1.47%
LGND A 1.46%
ARWR F 1.45%
BHVN B 1.42%
PTCT B 1.4%
FOLD B 1.38%
AGIO B 1.37%
APLS F 1.24%
ALKS F 1.21%
IOVA B 1.07%
FGEN F 1.05%
RGNX F 1.05%
CHRS F 0.99%
EBS B 0.96%
HRTX F 0.84%
INSM D 0.81%
KPTI C 0.79%
ESPR C 0.79%
ALLK B 0.76%
IRWD F 0.75%
FATE F 0.67%
EDIT F 0.66%
PBYI C 0.65%
MDGL A 0.59%
ADVM D 0.55%
ALLO D 0.54%
ANAB F 0.53%
SGMO A 0.48%
ENTA D 0.47%
EGRX F 0.42%
GTHX A 0.42%
ATRA C 0.41%
VKTX A 0.38%
ANIK F 0.37%
VNDA D 0.35%
TVTX B 0.33%
KOD B 0.29%
BBIO D 0.29%
NTLA F 0.29%
PGEN F 0.29%
DNLI C 0.28%
KRYS C 0.28%
GOSS F 0.27%
VYGR C 0.26%
MGNX C 0.25%
ALEC D 0.25%
CYTK F 0.25%
DVAX A 0.24%
YMAB A 0.24%
LABD Underweight 9 Positions Relative to PBE
Symbol Grade Weight
ILMN A -5.78%
MNKD A -3.48%
PTGX B -3.18%
BCRX A -2.83%
TECH B -2.82%
COLL F -2.74%
RGEN D -2.72%
QGEN D -2.64%
NVAX F -2.59%
Compare ETFs